Wendell P. Weeks,Robert Anthony Schaut,Steven Edward DeMartino,John Stephen Peanasky
申请号：
US14259255
公开号：
US20150071913A1
申请日:
2014.04.23
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, PERJETA (pertuzumab), ACTEMRA (tocilizumab), KADCYLA (trastuzumab emtansine), MetMAb (onartuzumab), obinutuzumab, ocrelizumab or lebrikizumab.
